Cardama Alfonso Quintas is Chief Medical Officer of Tcr2 Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Foghorn Therapeutics Inc.
25 Jan 24
4
Foghorn Therapeutics Inc.
13 Sep 23
3
Foghorn Therapeutics Inc.
13 Sep 23
4
TCR2 THERAPEUTICS INC.
1 Jun 23
4
TCR2 THERAPEUTICS INC.
19 Dec 22
4
TCR2 THERAPEUTICS INC.
13 Dec 22
4
TCR2 THERAPEUTICS INC.
9 Dec 22
4
TCR2 THERAPEUTICS INC.
7 Dec 22
4
TCR2 THERAPEUTICS INC.
5 Dec 22
4
TCR2 THERAPEUTICS INC.
18 Nov 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
24 Jan 24 | FHTX Foghorn Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 3.06 | 60,000 | 183.60 k | 60,000 |
11 Sep 23 | FHTX Foghorn Therapeutics | Stock Options Common Stock | Grant | Acquire A | No | No | 7.57 | 272,000 | 2.06 mm | 272,000 |
1 Jun 23 | TCRR Tcr2 Therapeutics | Common Stock | Sale back to company | Dispose D | No | No | 0 | 109,459 | 0.00 | 0 |
1 Jun 23 | TCRR Tcr2 Therapeutics | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 9,549 | 0.00 | 0 |
1 Jun 23 | TCRR Tcr2 Therapeutics | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 6,489 | 0.00 | 0 |
1 Jun 23 | TCRR Tcr2 Therapeutics | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 1,409 | 0.00 | 0 |
1 Jun 23 | TCRR Tcr2 Therapeutics | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 11,775 | 0.00 | 0 |
1 Jun 23 | TCRR Tcr2 Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 5.21 | 114,700 | 597.59 k | 0 |
1 Jun 23 | TCRR Tcr2 Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 5.88 | 90,720 | 533.43 k | 0 |
1 Jun 23 | TCRR Tcr2 Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 0.74 | 42,346 | 31.34 k | 0 |